Companies with a Future performance score of at least 3, ordered by Future performance score.
Circassia Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products.
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide.
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications.
Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally.
Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally.
Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom.
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide.
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of hospital-focused pharmaceuticals to treat unmet medical needs.
Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide.
Diaceutics Plc provides data analytics and implementation services for pharmaceutical companies worldwide.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Russia, Africa, and Asia.
Ergomed plc provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia.
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence.
MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally.
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide.